Steensma DP. How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes. Blood. 2018;132(16):1657-1663.

doi:10.1182/blood-2018-10-882118

In the sentence immediately before “Discussion: patient 4” on page 1660 in the 18 October 2018 issue, “avipiritinib (BLU-295)” should read “avapritinib (BLU-285).” The error has been corrected in the online version of the article.

2018

Sign in via your Institution

Steensma DP. How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes. Blood. 2018;132(16):1657-1663.

Cited By

Email alerts

ASH Publications

American Society of Hematology

Steensma DP. How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes. Blood. 2018;132(16):1657-1663.

This feature is available to Subscribers Only

My Account

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only